Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance. (2019)
Attributed to:
PRH/HHEX in intrahepatic cholangiocarcinoma, disease progression and response to chemotherapeutics.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/liv.14102
PubMed Identifier: 30903728
Publication URI: http://europepmc.org/abstract/MED/30903728
Type: Journal Article/Review
Volume: 39 Suppl 1
Parent Publication: Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3223